Press release
Mixed Mode Chromatography Resin Market Size Estimated to Reach US$ 743 Million at a CAGR of 15.7% by 2035
Mixed Mode Chromatography Resin Market
These resins utilize multimodal ligands, allowing for protein binding through a combination of ionic interactions, hydrogen bonding, and hydrophobic forces. This multifaceted binding mechanism offers superior selectivity, resolution, and loading capacity compared to traditional single-mode chromatography systems. The year 2024 marked a pivotal phase for the industry, driven by increasing demand for advanced separation technologies, particularly in the pharmaceutical and biotechnology sectors. Innovations in resin chemistry and growing bioprocessing applications have elevated the importance of mixed mode chromatography in areas such as monoclonal antibody purification, vaccines, and gene therapies. The market is set to gain further momentum as regulatory expectations and efficiency standards continue to rise in bioseparation processes.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7451
Country-Wise Analysis
The United States remains at the forefront of biopharmaceutical innovation, making it the most influential market for mixed mode chromatography resins. Its well-established R&D ecosystem, combined with the presence of leading biologics manufacturers, consistently drives demand for advanced purification technologies that support complex biologics production.
In India, the biopharmaceutical sector is rapidly expanding, fueled by cost-effective manufacturing capabilities and a growing clinical research environment. National initiatives such as "Make in India" and strategic support for biosimilar development have catalyzed infrastructure growth across biotech hubs, creating a strong foundation for increased adoption of mixed mode chromatography technologies.
China is also emerging as a dominant global force in biopharma, with substantial public and private investments directed toward biologics R&D. Government programs like "Healthy China 2030" are accelerating innovation in drug manufacturing, encouraging widespread uptake of modern purification solutions such as mixed mode chromatography resins.
The United Kingdom benefits from a strong academic research base and a vibrant biotech startup ecosystem, both of which contribute to consistent demand. As the country pushes further into personalized medicine and small-batch biologics, the need for high-efficiency, flexible purification methods is steadily growing, bolstering the mixed mode chromatography resins market.
Key Industry Players
Thermo Fisher Scientific
Cytiva (Danaher Corporation)
Merck KGaA (MilliporeSigma)
Agilent Technologies
Bio-Rad Laboratories, Inc.
Tosoh Corporation
GE Healthcare (now part of Cytiva in chromatography)
Purolite Corporation
Avantor (including VWR & Pall acquisitions)
JSR Micro Inc.
Kaneka Corporation
Sepragen Corporation
Repligen Corporation
Bio-Works Technologies
Competitive Landscape
The mixed-mode chromatography resin market is moderately concentrated, with key players such as Merck KGaA, Bio-Rad Laboratories, and Tosoh Corporation holding significant market shares. These companies actively compete through strategies centered on innovation, strategic collaborations, and capacity expansions to meet the rising demand for advanced purification solutions in biopharmaceutical manufacturing.
In 2024, Merck KGaA announced the expansion of its chromatography resin production capabilities. This move aims to support increasing global demand for high-performance resins used in the purification of monoclonal antibodies and other complex biologics, reflecting the growing scale and complexity of biopharma production pipelines.
Also in 2024, Bio-Rad Laboratories introduced a new line of high-performance ion-exchange chromatography resins tailored specifically for the biopharmaceutical industry. These resins are designed to deliver enhanced binding capacity and selectivity, addressing the escalating need for efficient protein purification technologies in biologics development.
Meanwhile, Tosoh Corporation continues to strengthen its position through R&D initiatives and quality-focused manufacturing, supporting global clients across biologics and biosimilar production. Collectively, these advancements highlight the sector's push toward greater efficiency, scalability, and process optimization in bioprocessing.
Browse Full Report: https://www.factmr.com/report/mixed-mode-chromatography-resin-market
Segmentation
By Type:
Ion Exchange-Hydrophobic Type
Hydroxyapatite Type
Others
By Application:
Antibodies Production
Vaccine Production
Non-antibody Proteins
Antibody-drug conjugate
Separation of low molecular weight impurities
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)
Check out More Related Studies Published by Fact.MR:
Genu Recurvatum Market
https://www.factmr.com/report/genu-recurvatum-market
Hemianopsia Market
https://www.factmr.com/report/hemianopsia-market
Chronic Idiopathic Constipation Treatment Market
https://www.factmr.com/report/chronic-idiopathic-constipation-treatment-market
Grand Mal Seizure Treatment Market
https://www.factmr.com/report/grand-mal-seizure-treatment-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mixed Mode Chromatography Resin Market Size Estimated to Reach US$ 743 Million at a CAGR of 15.7% by 2035 here
News-ID: 4084197 • Views: …
More Releases from Fact.MR
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding…
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners…
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering…
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance…
More Releases for Corporation
Endotherapy Devices Market Key Players: Hoya Corporation, Olympus Corporation, S …
A fresh report titled “Endotherapy Devices Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Endotherapy Devices Market. The competition analysis is also a major part of the report.
The global endotherapy devices market is projected to reach…
Digital Living Room Market 2017-2025 | Samsung Corporation, Sharp Corporation, B …
Global Digital Living Room Market: Snapshot
The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondary…
Global Healthcare Clinical Analytics Market to 2022| IBM Corporation, Cerner Cor …
Albany, NY, 3rd December : Recent research and the current scenario as well as future market potential of "Global Market Study on Healthcare Clinical Analytics: North America to be the Most Lucrative Market During the Assessment Period (2017 - 2022)" globally.
Introduction
Persistence Market Research delivers yet another unbiased, comprehensive and insightful report titled ‘Healthcare Clinical Analytics Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)’.
Get PDF for more Professional and Technical insights…
Endotherapy Devices Market Key Players : Hoya Corporation, Olympus Corporation, …
Endoscopy Devices Market is performed to examine abdominal pain, ulcers, digestive tract bleeding, and abnormal growths in the colon and other abdominal & gastrointestinal (GI) conditions. The minimally invasiveness of this procedure with fewer post operation complications makes it one of the most preferred and sought-after procedures in diagnostics and surgeries. The global endotherapy devices market is projected reach $5,015 million by 2024 from $3,369.0 million in 2017, growing at…
Endoscopy Devices Market Share with Olympus Corporation, HOYA Corporation, Fujif …
Endoscopy Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $40,854 million by 2022 from $27,273 million in 2015, registering a CAGR of 5.7% during the period 2016 to 2022. The flexible endoscopes are expected to dominate the global endoscopy devices market. North America is projected to continue its lead, accounting for more than one-third share of the global endoscopy devices market…
Digital Living Room Market 2017 - 2025 : Sharp Corporation, BenQ Corporation, So …
Global Digital Living Room Market: Snapshot
The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondary…
